Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 7 hours ago
With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
about 7 hours ago
The FDA has approved a new small molecule inhibitor from Celcuity with...
FDA plans to release more drug rejection letters as controversial policy resumes
about 9 hours ago
After pausing a controversial policy to publicly release drug rejection letters in...
Biogen defends anti-tau drug after stock slides on Alzheimer’s readout
about 10 hours ago
Biogen leaders took to an investor call today to defend the phase...
CEPI-backed Ebola vaccine set to enter phase 1 trials
about 12 hours ago
The first vaccine against the Bundibugyo ebola virus is poised to enter...
Chai brews up $400M series C to fuel AI molecule models used by Lilly, Novartis and Pfizer
about 14 hours ago
Chai Discovery has continued its whirlwind emergence, closing its third financing round...
Summit sells failed antibiotic to OpenAI-backed startup in $105M deal
about 14 hours ago
Summit Therapeutics has cleared out an asset from its pre-ivonescimab history, offloading...
AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline
about 15 hours ago
Biogen's leading tau-targeting candidate has slowed cognitive decline across a suite of...
Over half of clinical trial sites see recruitment hindered by inefficiencies: survey
about 15 hours ago
A total of 59% of clinical trial sites are seeing fewer eligible...
‘Neural tourniquet’ device could hold key to stopping life-threatening hemorrhage
about 15 hours ago
An ear-based wearable device that taps the body’s longest cranial nerve boosts...
Avere goes public via NextCure reverse merger, secures Hansoh IL-23 drug with $2.3B deal
about 18 hours ago
Avere Therapeutics has burst onto the scene by securing a public listing...
Spero pivots to I&I with $1.1B deal for Innovent antibody, sells slice of Utebzi royalties for $105M
about 18 hours ago
Spero Therapeutics is pivoting to immune and inflammation indications through a license...
Merck KGaA institutes in-office requirement for US research team that could lead to 70 layoffs
1 day ago
Merck KGaA’s U.S. research site has instituted a new in-office work requirement...